Perampanel as first add-on antiseizure medication: Italian consensus clinical practice statements
Abstract Background When use of a single antiseizure medication (ASM) fails to induce seizure remission, add-on therapy is justified. Perampanel (PER) is approved in Europe as adjunctive therapy for focal, focal to bilateral tonic-clonic seizures and generalized tonic-clonic seizures. Aim of the stu...
Guardat en:
| Autors principals: | , , , , , |
|---|---|
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
BMC
2021-10-01
|
| Col·lecció: | BMC Neurology |
| Matèries: | |
| Accés en línia: | https://doi.org/10.1186/s12883-021-02450-y |
| Etiquetes: |
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|